Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia

PHASE3CompletedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

September 30, 2005

Conditions
Leukemia
Interventions
DRUG

asparaginase

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

daunorubicin hydrochloride

DRUG

dexamethasone

DRUG

doxorubicin hydrochloride

DRUG

mercaptopurine

DRUG

methotrexate

DRUG

prednisone

DRUG

thioguanine

DRUG

vincristine sulfate

Trial Locations (20)

10032

Herbert Irving Comprehensive Cancer Center, New York

10461

Albert Einstein Clinical Cancer Center, The Bronx

13210

State University of New York - Upstate Medical University, Syracuse

15213

Children's Hospital of Pittsburgh, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

55905

Mayo Clinic Cancer Center, Rochester

61637

Saint Jude Midwest Affiliate, Peoria

77030

Baylor College of Medicine, Houston

94304

Lucile Packard Children's Hospital at Stanford, Palo Alto

98105

Children's Hospital and Regional Medical Center - Seattle, Seattle

90027-0700

Children's Hospital Los Angeles, Los Angeles

94143-0128

UCSF Comprehensive Cancer Center, San Francisco

20010-2970

Children's National Medical Center, Washington D.C.

46202-5289

Indiana University Cancer Center, Indianapolis

02115

Dana-Farber Cancer Institute, Boston

39216-4505

University of Mississippi Medical Center, Jackson

45229-3039

Children's Hospital Medical Center - Cincinnati, Cincinnati

97201-3098

Doernbecher Children's Hospital, Portland

77555-0361

University of Texas Medical Branch, Galveston

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00005603 - Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter